Preliminary safety, efficacy and immunogenicity results from a phase   1/2a study (DIRECT-01) of cancer neoantigen DNA vaccine VB10.NEO in   patients with locally advanced or metastatic solid tumors

Document type:: Meeting Abstract
Author(s):: Krauss, Jurgen; Krackhardt, Angela; Jaeger, Elke; Williams, Anja; Rafiyan, Reza; Wold, Hedda; Gerner, Lisa; Sekelja, Monika; Fredriksen, Agnete; Schjetne, Karoline; Axelsen, Mads; Fredriksen, Agnete; Wold, Hedda
Title:: Preliminary safety, efficacy and immunogenicity results from a phase 1/2a study (DIRECT-01) of cancer neoantigen DNA vaccine VB10.NEO in patients with locally advanced or metastatic solid tumors
Journal title abbreviation:: J Immunother Cancer
Year:: 2019
Journal volume:: 7 Suppl 1
TUM Institution:: III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: